 | This article needs to be updated. (January 2024) |
The research in Parkinson's disease (also known as clinical trials, medical research, research studies, or clinical studies) refers to any study intended to help answer questions about etiology, diagnostic approaches or new treatments of Parkinson's disease (PD) by studying their effects on human subjects. Clinical trials are designed and conducted by scientists and medical experts, who invite participants to undergo testing new vaccines, therapies, or treatments.[1]
Only a small fraction of patients with Parkinson's disease participate in clinical research and specially in clinical trials. When clinical trials lack participation, it causes a significant delay in the development of new drugs and treatments.[2]
- ^ "Clinical Trials Knowledge Center: Research Articles, FAQ's & More". Clinicaltrials.com. Retrieved 25 October 2013.
- ^ "Parkinson's Disease Clinical Trials". pdtrials. 3 July 2012. Retrieved 25 October 2013.